awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37662198-8E62798A-6F2E-41AB-B76B-E4039E1ABD67
Q37662198-8E62798A-6F2E-41AB-B76B-E4039E1ABD67
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37662198-8E62798A-6F2E-41AB-B76B-E4039E1ABD67
Changing paradigms in the treatment of chronic lymphocytic leukemia.
P2860
Q37662198-8E62798A-6F2E-41AB-B76B-E4039E1ABD67
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37662198-8E62798A-6F2E-41AB-B76B-E4039E1ABD67
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b1caee2647f6303e71893815a9a6438e9e01e2dc
P2860
Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia.